Sanofi’s President of North American Pharmaceuticals, Anne Whitaker, will step down next month, according to an internal memo reported by The Wall Street Journal blog Pharmalot.
In a note to employees, Peter Guenter, Executive VP for global commercial operations, is reported to say Whitaker is leaving for “another opportunity,” but omits further details.
Whitaker joined Sanofi from GSK in September 2011 and oversees all North American operations including the Diabetes, Oncology, Cardiovascular units, US market access, US medical affairs, business strategy, planning and operations, Chattem (Consumer Healthcare), and Canada Pharmaceuticals. She is a member of the Global Management Committee, the Global Operations Committee and the U.S. Regional Strategic Management Committee.
Copyright - Unless otherwise stated all contents of this web site are © 2015 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
in-Pharmatechnologist.com takes a look at the People on the Move this week.
The WHO Executive Board prepares for a special Ebola meeting, CEO leaves troubled biotech, and senior staff...
Novartis's CEO becomes President of EFPIA, a new head of R&D for Genentech, and more People on...